Your browser doesn't support javascript.
loading
Loss of RUNX1 function results in enhanced granulocyte-colony-stimulating factor-mediated mobilization.
Lam, K; Muselman, A; Du, R; Yan, M; Matsuura, S; Zhang, D-E.
Affiliation
  • Lam K; Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Muselman A; Divison of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
  • Du R; Divison of Biological Sciences, University of California, San Diego, La Jolla, CA, USA.
  • Yan M; Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Matsuura S; Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Zhang DE; Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Blood Cancer J ; 6: e407, 2016 Mar 25.
Article in En | MEDLINE | ID: mdl-27015284
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance / Hematopoietic Stem Cells / Granulocyte Colony-Stimulating Factor / Hematopoietic Stem Cell Mobilization / Core Binding Factor Alpha 2 Subunit Limits: Humans Language: En Journal: Blood Cancer J Year: 2016 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance / Hematopoietic Stem Cells / Granulocyte Colony-Stimulating Factor / Hematopoietic Stem Cell Mobilization / Core Binding Factor Alpha 2 Subunit Limits: Humans Language: En Journal: Blood Cancer J Year: 2016 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos